Agiliti, Inc. provides healthcare technology management and service solutions to the healthcare industry in the United States. The company offers onsite managed services, including programs for the management, reprocessing, and logistics of medical equipment at individual facilities and integrated delivery networks to monitor and adjust equipment quantities and availability to address fluctuations in patient census and acuity; and clinical engineering services comprising maintenance, repair, and remediation solutions for various type of medical equipment, including general biomedical and diagnostic imaging equipment through supplemental and outsourced offerings. It also provides equipment solutions, which primarily provide supplemental, peak need, and per-case rental of general biomedical, specialty, and surgical equipment to acute care hospitals and alternate site providers, including premier healthcare institutions and integrated delivery networks. As of December 31, 2020, it owned or managed approximately a million units of medical equipment for approximately 7,000 national, regional, and local acute care hospitals, health system integrated delivery networks, and alternate site providers. Agiliti, Inc. was founded in 2018 and is headquartered in Minneapolis, Minnesota.
IPO Year: 2021
Exchange: NYSE
Website: agilitihealth.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/7/2024 | $10.00 | Buy → Neutral | UBS |
| 2/6/2024 | Sector Weight | KeyBanc Capital Markets | |
| 1/4/2024 | $23.00 | Buy | Craig Hallum |
| 11/14/2023 | $16.00 → $10.00 | Neutral → Buy | UBS |
| 9/5/2023 | $18.00 → $11.00 | Neutral → Underperform | BofA Securities |
| 8/24/2023 | $15.00 → $10.00 | Equal-Weight → Underweight | Morgan Stanley |
| 8/15/2023 | $20.00 → $13.00 | Buy → Neutral | Citigroup |
| 8/10/2023 | Outperform → Mkt Perform | Raymond James | |
| 1/6/2023 | Overweight → Equal-Weight | Morgan Stanley | |
| 12/16/2022 | $19.00 | Buy → Neutral | BofA Securities |
NEW YORK, April 30, 2024 /PRNewswire/ -- DigitalOcean Holdings Inc. (NYSE:DOCN) will replace Agiliti Inc. (NYSE:AGTI) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, May 7. Thomas H. Lee Partners L.P. is acquiring Agiliti in a deal expected to be completed on or about that date pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector May 7, 2024 S&P SmallCap 600 Addition DigitalOcean Holdings DOCN Information Technology S&P SmallCap 600 Deletion Agiliti AGTI Health Care For more information about S&P Dow Jones Indices,
Tom Leonard returns as Chief Executive Officer Agiliti, Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of medical technology management and service solutions to the healthcare industry, today announced that the Agiliti Board of Directors has appointed Tom Leonard as Chief Executive Officer. Leonard succeeds Tom Boehning who is no longer with the company. Leonard previously served as CEO of Agiliti from April 2015 until his retirement from the company in March 2023. He served as a member of the company's Board of Directors following his retirement and will remain a Board member as he returns to the role of CEO. "Tom Leonard led the company through eight years of profitable growth
Board Appointments Support the Company's Previously Announced Board Transition Plan Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading national home health and hospice provider, today announced an agreement with Cruiser Capital Advisors LLC ("Cruiser") and Harbour Point Capital Management LP ("Harbour Point" ), which collectively own approximately 4.7% of the outstanding shares of Enhabit's common stock, pursuant to which Enhabit has appointed Stuart McGuigan and Barry Schochet to its board of directors, effective immediately. With these appointments the Company's board will expand temporarily to 13 directors. As Enhabit previously disclosed in May 2022 ahead of the complet
SC 13G - AGILITI, INC. \DE (0001749704) (Subject)
UBS downgraded Agiliti from Buy to Neutral and set a new price target of $10.00
KeyBanc Capital Markets initiated coverage of Agiliti with a rating of Sector Weight
Craig Hallum initiated coverage of Agiliti with a rating of Buy and set a new price target of $23.00
UBS upgraded Agiliti from Neutral to Buy and set a new price target of $10.00 from $16.00 previously
BofA Securities downgraded Agiliti from Neutral to Underperform and set a new price target of $11.00 from $18.00 previously
Morgan Stanley downgraded Agiliti from Equal-Weight to Underweight and set a new price target of $10.00 from $15.00 previously
Citigroup downgraded Agiliti from Buy to Neutral and set a new price target of $13.00 from $20.00 previously
Raymond James downgraded Agiliti from Outperform to Mkt Perform
Morgan Stanley downgraded Agiliti from Overweight to Equal-Weight
BofA Securities downgraded Agiliti from Buy to Neutral and set a new price target of $19.00
15-12G - AGILITI, INC. \DE (0001749704) (Filer)
EFFECT - AGILITI, INC. \DE (0001749704) (Filer)
10-Q - AGILITI, INC. \DE (0001749704) (Filer)
25-NSE - AGILITI, INC. \DE (0001749704) (Subject)
S-8 POS - AGILITI, INC. \DE (0001749704) (Filer)
POS AM - AGILITI, INC. \DE (0001749704) (Filer)
SC 13E3/A - AGILITI, INC. \DE (0001749704) (Subject)
8-K - AGILITI, INC. \DE (0001749704) (Filer)
SC 13E3/A - AGILITI, INC. \DE (0001749704) (Subject)
DEFM14C - AGILITI, INC. \DE (0001749704) (Filer)
Agiliti Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of healthcare technology management and service solutions to the healthcare industry, today announced its financial results for the fourth quarter and year ended December 31, 2023. Fourth Quarter 2023 Highlights Revenue growth of 4% to $292 million Net loss of $5.7 million, compared to net income of $3.4 million in the prior year period; diluted loss per share of $0.04, compared to diluted earnings per share of $0.02 in the prior year period Adjusted EBITDA1 of $67.3 million, compared to $71.4 million in the prior year period; Adjusted Earnings Per Share1 of $0.13, compared to $0.18 in the prior year period Full-Yea
Unanimously Recommended by Special Committee of the Agiliti Board of Directors Agiliti Shareholders to Receive $10.00 per Share in Cash, Representing Premia of 39% and 43% Over Agiliti's 30-Day and 90-Day Volume Weighted Average Price Agiliti Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of medical technology management and service solutions to the healthcare industry, today announced that it has entered into a definitive merger agreement pursuant to which an affiliate of private equity firm Thomas H. Lee Partners, L.P. ("THL"), the company's majority shareholder, will acquire all outstanding shares of Agiliti common stock not currently owned by THL and its affiliates and certain
Agiliti Inc. (NYSE:AGTI) ("Agiliti") today announced that the company will release its fourth quarter and full year 2023 financial results after the market close on Tuesday, March 5, 2024, to be followed by a conference call at 5 p.m. Eastern Time on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0792 or for international callers, 1-201-689-8263. The passcode for the live call is 13743834. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The Access ID for the replay call is 13743834. The replay will be available until March 19, 2024. Interested inve
Agiliti Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of healthcare technology management and service solutions to the healthcare industry, today announced its financial results for the third quarter ended September 30, 2023, and reaffirmed its financial outlook for the full year. Third Quarter 2023 Highlights Revenue growth of 7.5% to $291.6 million Net loss of $12.7 million, compared to net income of $2.0 million in the prior year period; loss per share of $0.09, compared to earnings per share of $0.01 per share in the prior year period Adjusted EBITDA1 of $62.0 million, compared to $66.5 million in the prior year period; Adjusted Earnings Per Share1 of $0.09, compared
Agiliti Inc. (NYSE:AGTI) ("Agiliti") today announced that the company will release its third quarter 2023 financial results after the market close on Tuesday, November 7, 2023, to be followed by a conference call at 5 p.m. Eastern Time on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0792 or for international callers, 1-201-689-8263. The passcode for the live call is 13741317. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The Access ID for the replay call is 13741317. The replay will be available until November 21, 2023. Interested investors and
Agiliti Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of healthcare technology management and service solutions to the United States healthcare industry, today announced its financial results for the second quarter ended June 30, 2023, and revised its financial outlook for 2023. Second Quarter 2023 Highlights Revenue growth of 6.2% to $291 million Net loss of $4 million, compared to net income of $5 million in the prior year period; loss per share of $0.03, compared to income per share of $0.04 per share in the prior year period Adjusted EBITDA1 of $66 million, compared to $70 million in the prior year period; Adjusted Earnings Per Share1 of $0.14, compared to $0.19 in the
Agiliti Inc. (NYSE:AGTI) ("Agiliti") today announced that the company will release its second quarter 2023 financial results after the market close on Tuesday, August 8, 2023, to be followed by a conference call at 5 p.m. Eastern Time on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0792 or for international callers, 1-201-689-8263. The passcode for the live call is 13739397. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The Access ID for the replay call is 13739397. The replay will be available until August 22, 2023. Interested investors and ot
Agiliti Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of healthcare technology management and service solutions to the United States healthcare industry, today announced its financial results for the first quarter ended March 31, 2023, and reaffirmed its financial outlook for 2023. First Quarter 2023 Highlights Revenue growth of 1.9% to $300 million Net income of $3 million, down $16.9 million from the prior year period; diluted income per share of $0.02, down $0.12 per share from the prior year period Adjusted EBITDA1 of $72 million, compared to $89 million in the prior year period; Adjusted Earnings Per Share1 of $0.20, down $0.09 compared to the prior year period "Our
Agiliti Inc. (NYSE:AGTI) ("Agiliti") today announced that the company will release its first quarter 2023 financial results after the market close on Tuesday, May 9, 2023, to be followed by a conference call at 5 p.m. Eastern Time on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0792 or for international callers, 1-201-689-8263. The passcode for the live call is 13737749. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The Access ID for the replay call is 13737749. The replay will be available until May 16, 2023. Interested investors and other par
Agiliti, Inc. (NYSE:AGTI) ("Agiliti") today announced that the company will release its fourth quarter and full year 2022 financial results after the market close on Tuesday, March 7, 2023, to be followed by a conference call at 5 p.m. Eastern Time on the same day. The conference call can be accessed live over the phone by dialing 1-844-512-2921 or for international callers, 1-412-317-6671. The passcode for the live call is 13735716. A replay will be available two hours after the call and can be accessed by dialing 1-877-407-0792, or for international callers, 1-201-689-8263. The Access ID for the replay call is 13735716. The replay will be available until March 14, 2023. Interested inves
Agiliti Taken Private for $10.00 per Share in Cash Agiliti Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of medical technology management and service solutions to the healthcare industry, today announced the closing of its acquisition by an affiliate of private equity firm Thomas H. Lee Partners, L.P. ("THL"). On February 26, 2024, Agiliti announced that THL had signed a definitive agreement to purchase all outstanding shares of Agiliti common stock not currently owned by THL and its affiliates or certain management and director shareholders for $10.00 per share, implying a total enterprise value of $2.5 billion. "The work we do at Agiliti has strengthened our nation's healthcar
NEW YORK, April 30, 2024 /PRNewswire/ -- DigitalOcean Holdings Inc. (NYSE:DOCN) will replace Agiliti Inc. (NYSE:AGTI) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, May 7. Thomas H. Lee Partners L.P. is acquiring Agiliti in a deal expected to be completed on or about that date pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector May 7, 2024 S&P SmallCap 600 Addition DigitalOcean Holdings DOCN Information Technology S&P SmallCap 600 Deletion Agiliti AGTI Health Care For more information about S&P Dow Jones Indices,
Agiliti Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of healthcare technology management and service solutions to the healthcare industry, today announced its financial results for the fourth quarter and year ended December 31, 2023. Fourth Quarter 2023 Highlights Revenue growth of 4% to $292 million Net loss of $5.7 million, compared to net income of $3.4 million in the prior year period; diluted loss per share of $0.04, compared to diluted earnings per share of $0.02 in the prior year period Adjusted EBITDA1 of $67.3 million, compared to $71.4 million in the prior year period; Adjusted Earnings Per Share1 of $0.13, compared to $0.18 in the prior year period Full-Yea
Unanimously Recommended by Special Committee of the Agiliti Board of Directors Agiliti Shareholders to Receive $10.00 per Share in Cash, Representing Premia of 39% and 43% Over Agiliti's 30-Day and 90-Day Volume Weighted Average Price Agiliti Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of medical technology management and service solutions to the healthcare industry, today announced that it has entered into a definitive merger agreement pursuant to which an affiliate of private equity firm Thomas H. Lee Partners, L.P. ("THL"), the company's majority shareholder, will acquire all outstanding shares of Agiliti common stock not currently owned by THL and its affiliates and certain
Agiliti Inc. (NYSE:AGTI) ("Agiliti") today announced that the company will release its fourth quarter and full year 2023 financial results after the market close on Tuesday, March 5, 2024, to be followed by a conference call at 5 p.m. Eastern Time on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0792 or for international callers, 1-201-689-8263. The passcode for the live call is 13743834. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The Access ID for the replay call is 13743834. The replay will be available until March 19, 2024. Interested inve
Agiliti Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of healthcare technology management and service solutions to the healthcare industry, today announced its financial results for the third quarter ended September 30, 2023, and reaffirmed its financial outlook for the full year. Third Quarter 2023 Highlights Revenue growth of 7.5% to $291.6 million Net loss of $12.7 million, compared to net income of $2.0 million in the prior year period; loss per share of $0.09, compared to earnings per share of $0.01 per share in the prior year period Adjusted EBITDA1 of $62.0 million, compared to $66.5 million in the prior year period; Adjusted Earnings Per Share1 of $0.09, compared
Agiliti Inc. (NYSE:AGTI) ("Agiliti") today announced that the company will release its third quarter 2023 financial results after the market close on Tuesday, November 7, 2023, to be followed by a conference call at 5 p.m. Eastern Time on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0792 or for international callers, 1-201-689-8263. The passcode for the live call is 13741317. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The Access ID for the replay call is 13741317. The replay will be available until November 21, 2023. Interested investors and
Tom Leonard returns as Chief Executive Officer Agiliti, Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of medical technology management and service solutions to the healthcare industry, today announced that the Agiliti Board of Directors has appointed Tom Leonard as Chief Executive Officer. Leonard succeeds Tom Boehning who is no longer with the company. Leonard previously served as CEO of Agiliti from April 2015 until his retirement from the company in March 2023. He served as a member of the company's Board of Directors following his retirement and will remain a Board member as he returns to the role of CEO. "Tom Leonard led the company through eight years of profitable growth
Agiliti Inc. (NYSE:AGTI) ("Agiliti") today announced that the company will participate at the Morgan Stanley Global Healthcare Conference on September 12, 2023, in New York City. Management will host 1x1 investor meetings as well as a fireside chat at 12:15 p.m. Eastern Time on the same day, September 12, 2023. Interested investors and other parties may also listen to a simultaneous webcast of the fireside chat by logging onto the Investor Relations section of the Company's website at https://investors.agilitihealth.com. The online replay will be available for a limited time shortly following the call. About Agiliti Agiliti is an essential service provider to the U.S. healthcare indus
Agiliti Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of healthcare technology management and service solutions to the United States healthcare industry, today announced that its board of directors approved a share repurchase program that grants the Company authority to repurchase up to $50 million of shares of the Company's common stock (exclusive of any fees, commissions or other expenses related to such repurchases), over a 12-month period. "The Board's authorization of a share repurchase program reflects confidence in the Company's long-term strategy and the value we see in our shares relative to our future outlook. We remain committed to driving value for our customers, employe
4 - AGILITI, INC. \DE (0001749704) (Issuer)
4 - AGILITI, INC. \DE (0001749704) (Issuer)
4 - AGILITI, INC. \DE (0001749704) (Issuer)
4 - AGILITI, INC. \DE (0001749704) (Issuer)
4 - AGILITI, INC. \DE (0001749704) (Issuer)
4 - AGILITI, INC. \DE (0001749704) (Issuer)
4 - AGILITI, INC. \DE (0001749704) (Issuer)
4 - AGILITI, INC. \DE (0001749704) (Issuer)
4 - AGILITI, INC. \DE (0001749704) (Issuer)
4 - AGILITI, INC. \DE (0001749704) (Issuer)
DigitalOcean Holdings, Inc. (NYSE:DOCN) is set to release earnings results for its first quarter before the opening bell on May 10, 2024. Analysts expect the New York-based company to report quarterly earnings at 38 cents per share, up from 28 cents per share in the year-ago period. DigitalOcean is projected to report quarterly revenue of $182.58 million, compared to $165.13 million a year ago, according to data from Benzinga Pro. DigitalOcean replaced Agiliti Inc. (NYSE:AGTI) in the S&P SmallCap 600 on Tuesday, May 7. DigitalOcean shares fell 3.2% to close at $32.58 on Thursday. Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can
Thomas H. Lee Partners L.P. is acquiring Agiliti in a deal expected to be completed on or about that date pending final condition
Raymond James analyst John Ransom maintains Agiliti (NYSE:AGTI) from Market Perform to Market Perform.
UBS analyst Kevin Caliendo downgrades Agiliti (NYSE:AGTI) from Buy to Neutral and announces $10 price target.
Agiliti (NYSE:AGTI) reported its Q4 earnings results on Tuesday, March 5, 2024 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Agiliti beat estimated earnings by 18.0%, reporting an EPS of $0.13 versus an estimate of $0.11. Revenue was up $10.31 million from the same period last year. Past Earnings Performance Last quarter the company missed on EPS by $0.0 which was followed by a 13.0% increase in the share price the next day. Here's a look at Agiliti's past performance: Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022 EPS Estimate 0.09 0.15 0.16 0.17 EPS Actual 0.09 0.14 0.20 0.18 Revenue Estimate 280.47M 284.25M 288.44M 272.74M Revenue Actual 291.63M 29
Agiliti (NYSE:AGTI) reported quarterly earnings of $0.130 per share which beat the analyst consensus estimate of $0.120 by 8.33 percent. The company reported quarterly sales of $292.000 million which missed the analyst consensus estimate of $292.391 million by 0.13 percent. This is a 3.66 percent increase over sales of $281.679 million the same period last year.
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion. • Target (NYSE:TGT) is estimated to report quarterly earnings at $2.22 per share on revenue of $29.33 billion. • 2seventy bio (NASDAQ:TSVT) is expected to report quarterly loss at $0.99 per share on revenue of $14.71 million. • CLPS (NASDAQ:CLPS) is expected to report earnings for its first quarter. • Seres Therapeutics (NASDAQ:MCRB) is projected to report quarterly loss at $0.50 per share on revenue of $350 thousand. • Vivid Seats (NASDAQ:SEAT) is expected to report quarterly earnings at $0.06 per share on revenue of $183.67 million. • Nuwellis (N
Agiliti (NYSE:AGTI) is set to give its latest quarterly earnings report on Tuesday, 2024-03-05. Here's what investors need to know before the announcement. Analysts estimate that Agiliti will report an earnings per share (EPS) of $0.11. Agiliti bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter. New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast). Past Earnings Performance Last quarter the company missed EPS by $0.00, which was followed by a 12.93% increase in the share price the next
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning lower on Monday. The Dow traded down 0.08% to 39,101.76 while the NASDAQ rose 0.04% to 16,003.09. The S&P 500 also fell, dropping, 0.24% to 5,076.80. Check This Out: Intuitive Machines, Marriott International And 2 Other Stocks Insiders Are Selling Leading and Lagging Sectors Energy shares rose by 0.5% on Monday. In trading on Monday, utilities shares fell by 1.7%. Top Headline Pilgrim's Pride Corporation (NASDAQ:PPC) posted better-than-expected fourth-quarter results. Pilgrims Pride reported fourth-quarter fiscal 2023 sales growth of 9.7% year-over-year to $4.528 billion, beating the c
Shares of Freshpet, Inc. (NASDAQ:FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results. Freshpet posted quarterly earnings of 31 cents per share, beating market estimates of 5 cents per share. The company’s quarterly sales came in at $215.42 million versus expectations of $204.36 million. Freshpet shares gained 15.5% to $106.29 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Akili, Inc. (NASDAQ:AKLI) shares jumped 126% to $0.5009 after the company reported positive results from Shionogi's Phase 3 clinical trial of localized version of Akili's EndeavorRx® for Pediatric ADHD patients in Japan. Z